Comparative pharmacokinetics of oxytetracycline in blunt-snout bream (Megalobrama amblycephala) with single and multiple-dose oral administration

被引:0
|
作者
Ru-Qin Li
Yu-Wei Ren
Jing Li
Can Huang
Jun-hui Shao
Xiao-Xuan Chen
Zhi-Xin Wu
机构
[1] Freshwater Aquaculture Collaborative Innovation Center,Department of Aquatic Animal Medicine, College of Fisheries, Huazhong Agricultural University, Key Lab of Freshwater Animal Breeding, Ministry of Agriculture
来源
Fish Physiology and Biochemistry | 2015年 / 41卷
关键词
Pharmacokinetics; Oxytetracycline; Oral administration;
D O I
暂无
中图分类号
学科分类号
摘要
Research into the pharmacokinetics and residue elimination of oxytetracycline (OTC) is important both to determine the optimal dosage regimens and to establish a safe withdrawal time in fish. A depletion study is presented here for OTC in Megalobrama amblycephala with a single-dose (100 mg/kg) and multiple-dose (100 mg/kg for five consecutive days) oral administration. The study was conducted at 25 °C. As a result, a one-compartment model was developed. For the single dose, the absorption half-life was 5.79, 9.40, 6.96, and 8.06 h in the plasma, liver, kidney, and muscle, respectively. However, the absorption half-life was 3.62, 7.33, 4.59, and 6.02 h with multiple-dose oral administration. The elimination half-time in the plasma, liver, kidney, and muscle was 58.63, 126.43, 65.1, and 58.85 h when M. amblycephala was treated with a single dose. However, the elimination half-time changed to 91.75, 214.87, 126.22, and 135.84 h with multiple-dose oral administration.
引用
收藏
页码:803 / 809
页数:6
相关论文
共 50 条
  • [41] Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
    Chen, Lulu
    Zhou, Luping
    Huang, Jie
    Wang, Yaqin
    Yang, Guoping
    Tan, Zhirong
    Wang, Yicheng
    Zhou, Gan
    Liao, Jianwei
    Ouyang, Dongsheng
    FRONTIERS IN PHARMACOLOGY, 2018, 8
  • [42] Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
    Flanagan, Shawn D.
    Bien, Paul A.
    Munoz, Kelly A.
    Minassian, Sonia L.
    Prokocimer, Philippe G.
    PHARMACOTHERAPY, 2014, 34 (03): : 240 - 250
  • [43] Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
    Ramael, S
    De Smedt, F
    Toublanc, N
    Otoul, C
    Boulanger, P
    Riethuisen, JM
    Stockis, A
    CLINICAL THERAPEUTICS, 2006, 28 (05) : 734 - 744
  • [44] Pharmacokinetics of opicapone, a third-generation COMT inhibitor, after single and multiple oral administration: A comparative study in the rat
    Goncalves, Daniela
    Alves, Gilberto
    Fortuna, Ana
    Soares-da-Silva, Patricio
    Falcao, Amilcar
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 323 : 9 - 15
  • [45] Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers
    Modi, Nishit B.
    Cheng, Xiaoli
    Mattheakis, Larry
    Hwang, Ching-Chang
    Nawabi, Roya
    Liu, David
    Gupta, Suneel
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (11): : 1263 - 1278
  • [46] Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants
    Aslanis, Vassilios
    Slack, Robert J.
    MacKinnon, Alison C.
    McClinton, Catherine
    Tantawi, Susan
    Gravelle, Lise
    Nilsson, Ulf J.
    Leffler, Hakon
    Brooks, Ashley
    Khindri, Sanjeev K.
    Marshall, Richard P.
    Pedersen, Anders
    Schambye, Hans
    Zetterberg, Fredrik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (03) : 267 - 280
  • [47] Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants
    Vassilios Aslanis
    Robert J. Slack
    Alison C. MacKinnon
    Catherine McClinton
    Susan Tantawi
    Lise Gravelle
    Ulf J. Nilsson
    Hakon Leffler
    Ashley Brooks
    Sanjeev K. Khindri
    Richard P. Marshall
    Anders Pedersen
    Hans Schambye
    Fredrik Zetterberg
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 267 - 280
  • [48] Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
    Hirawat, Samit
    Welch, Ellen M.
    Elfring, Gary L.
    Northcutt, Valerie J.
    Paushkin, Sergey
    Hwang, Seongwoo
    Leonard, Eileen M.
    Almstead, Neil G.
    Ju, William
    Peltz, Stuart W.
    Miller, Langdon L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04) : 430 - 444
  • [49] Pharmacokinetic properties of isradipine after single-dose and multiple-dose oral administration in Chinese volunteers: a randomized, open-label, parallel-group phase I study
    Wang, Yanran
    Jin, Zhaohui
    Wang, Zhijun
    Jiang, Xuehua
    Wang, Ling
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (12) : 1664 - 1670
  • [50] Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, Following Single-and Multiple-Dose Administration to Healthy Male Adult Volunteers
    Tinsley, Jon
    Robinson, Neil
    Davies, Kay E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (06) : 698 - 707